Predictors of outcome in myxoedema coma
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 12 (1), 111
- https://doi.org/10.1186/cc6218
Abstract
Myxoedema coma is a rare and life-threatening illness the outcome of which has not been robustly studied in large numbers, partly due to its low incidence. Dutta and colleagues have explored outcome predictors in a developing country where access to thyroid function tests is more limited than in the Western world. Cardiovascular instability, reduced consciousness, persistent hypothermia, and sepsis all contributed to a poorer outcome, as has been demonstrated before, but a generic outcome predictor model was shown to be useful in this group of patients. Unfortunately, this observational study was unable to show differences in outcome based on replacement treatment methods and the mortality remains at 40%.Keywords
This publication has 11 references indexed in Scilit:
- Predictors of outcome in myxoedema coma: a study from a tertiary care centreCritical Care, 2008
- Myxedema ComaEndocrinology and Metabolism Clinics of North America, 2006
- Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institutionJournal of Endocrinology, 2004
- Myxedema ComaReviews in Endocrine and Metabolic Disorders, 2003
- Myxedema Coma of Both Primary and Secondary Origin, with Non-Classic Presentation and Extremely Elevated Creatine KinaseHormone and Metabolic Research, 2000
- Factors Associated with Mortality of Myxedema Coma: Report of Eight Cases and Literature SurveyThyroid®, 1999
- Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatmentIntensive Care Medicine, 1991
- Thyroid Storm and Myxedema ComaMedical Clinics of North America, 1985
- Treatment of myxoedema coma factors associated with fatal outcomeActa Endocrinologica, 1985
- Management of myxedema coma: report on three successfully treated cases with nasogastric or intravenous administration of triiodothyronineJournal of Endocrinological Investigation, 1982